Topics
CNS Tumors | Treatment | Immunotherapy | CAR T-cells
Home > Publications > Topics > CNS Tumors > Treatment > Immunotherapy > CAR T-cells
Posey AD Jr, Young RM, June CH.
Future
perspectives on engineered T cells for cancer.
Trends
Cancer. 2024 Jun 8:S2405-8033(24)00097-9. doi:
10.1016/j.trecan.2024.05.007. PMID:
38853073. Review.
ˍ
Del Baldo G, Carai A, Mastronuzzi A.
Chimeric
antigen receptor adoptive immunotherapy in central nervous system
tumors: state of the art on clinical trials, challenges, and
emerging strategies to addressing them.
Curr
Opin Oncol. 2024 Jul 12. doi:
10.1097/CCO.0000000000001076. PMID:
38989708. Review. ˍ
Testa U, Castelli G, Pelosi E.
CAR-T
Cells in the Treatment of Nervous System Tumors.
Cancers
(Basel). 2024 Aug 22;16(16):2913. doi:
10.3390/cancers16162913. PMID:
39199683. Review. ˍ
Zhou D, Zhu X, Xiao Y.
Advances
in CAR-T therapy for central nervous system tumors.
Biomark
Res. 2024 Nov 6;12(1):132. doi:
10.1186/s40364-024-00679-6. PMID:
39506843. Review. ˍ
Pfeffer LK, Fischbach F, Heesen C, Friese MA.
Current
state and perspectives of CAR T cell therapy in central nervous
system diseases.
Brain.
2024 Nov 12:awae362. doi:
10.1093/brain/awae362. PMID:
39530593. Review˰ ˍ
Uslu U, June CH.
Beyond
the blood: expanding CAR T cell therapy to solid tumors.
Nat
Biotechnol. 2024 Nov 12. doi:
10.1038/s41587-024-02446-2. PMID:
39533105. Perspective˰
ˍ
Ismail FS, Gallus M, Meuth SG, Okada H, Hartung HP, Melzer N.
Current and
Future Roles of Chimeric Antigen
Receptor T-Cell Therapy in Neurology: A Review.
JAMA
Neurol. 2024 Nov 25. doi:
10.1001/jamaneurol.2024.3818. PMID:
39585688. Review˰ ˍ